Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Army
Argus Health
UBS
Deloitte
US Department of Justice

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 8,236,850

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,236,850
Title:Dimeric derivatives of artemisinin and application in anticancer therapy
Abstract: The present invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin of formula (I): or a pharmaceutically acceptable salt thereof with B.sub.1 and B.sub.2 selected from C.dbd.O, CHOH and CH.sub.2, as well as to their use in treating cancer and to their preparation method. ##STR00001##
Inventor(s): Begue; Jean-Pierre (Paris, FR), Bonnet-Delpon; Danielle (Paris, FR), Crousse; Beno t (Igny, FR), Grellepois; Fabienne (Reims, FR), Chollet; Constance (Montrouge, FR), Fahy; Jacques (Labruguiere, FR), Mordant; Celine (Saint Julien En Genevois, FR)
Assignee: Pierre Fabre Medicament (Boulogne-Billancourt, FR) Centre National de la Recherche Scientifique (Paris, FR) Universite Paris-Sud 11 (Orsay, FR)
Application Number:12/808,828
Patent Claims:see list of patent claims

Details for Patent 8,236,850

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Pierre Fabre Medicament (Boulogne-Billancourt, FR) Centre National de la Recherche Scientifique (Paris, FR) Universite Paris-Sud 11 (Orsay, FR) 2027-12-21 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Chubb
Covington
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.